Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab.

Parisi, Rose; Cowen, Emily A; Gu, Stephanie; Dusza, Stephen; Pulitzer, Melissa; Geyer, Mark B; King, Amber C; Markova, Alina

Parisi, Rose; Cowen, Emily A; Gu, Stephanie; Dusza, Stephen; Pulitzer, Melissa; Geyer, Mark B; King, Amber C; Markova, Alina.

Affiliation

Parisi R; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cowen EA; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gu S; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Dusza S; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pulitzer M; Department of Pathology and Laboratory Medicine, Dermatopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Geyer MB; Weill Cornell Medical College, Cornell University, New York, NY, USA.
King AC; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Markova A; Department of Pharmacy, Clinical Services, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Leuk Lymphoma ; 64(9): 1583-1587, 2023 09.

Article de En | MEDLINE | ID: mdl-37309201

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome malin non hodgkinien / Leucémie-lymphome lymphoblastique à précurseurs B / Anticorps bispécifiques / Leucémie-lymphome lymphoblastique à précurseurs B et T / Antinéoplasiques Limites: Humans Langue: En Journal: Leuk Lymphoma Sujet du journal: HEMATOLOGIA / NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google